SUN-051 CAM2029, an Octreotide Subcutaneous Depot, Provides Long-Term and Sustained Biochemical Control of Acromegaly: Final Analysis of the Core Part of the ACROINNOVA 2 Phase 3 Trial
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2025-12-02 15:24:12 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1210/jendso/bvaf149.1636
文献链接: https://academic.oup.com/jes/article/doi/10.1210/jendso/bvaf149.1636/8299785
其他信息:
出版社: The Endocrine Society
作者: Joanna L Spencer-Segal; Julie M Silverstein; Aleksandra Gillis-Janusewska; Guzin Fidan Yaylali; Elena Isaeva; Monica R Gadelha; Beverly M K Biller; Pietro Maffei; Maria Fleseriu; Alberto M Pedroncelli; Jacob Råstam; Maria Harrie; Agneta Svedberg; Fredrik Tiberg; Diego Ferone
全文下载地址: https://academic.oup.com/jes/article-pdf/9/Supplement_1/bvaf149.1636/64867095/bvaf149.1636.pdf
